GlaxoSmithKline PharmaceuticalsGLAXO 
$35.131.00%24h
1.00%24h
Global rank2461
Market cap$5.95B
Change 7d-0.87%
YTD Performance54.47%
SP500 benchmarkOutperform
P/E0.97
P/S15.34
Revenue$387.97M
Earnings$72.86M
Dividend yield-
Main Sector
Healthcare
Category
EPS for GlaxoSmithKline Pharmaceuticals (GLAXO)
GlaxoSmithKline Pharmaceuticals has an EPS of $36.05. In 2022, the company made an earnings per share (EPS) of $100.04. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for GLAXO
-
Value:-
EPS history for GlaxoSmithKline Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $36.05 | -63.96% |
| 2022 | $100.04 | 373.23% |
| 2021 | $21.14 | 284.36% |
| 2020 | $5.50 | - |
View the highest EPS stocks
